🗞️ Artificial intelligence fully automated analysis of handheld #echocardiography in real-world patients with suspected #heartfailure European Society of Cardiology Journals Giuseppe Galati Amr Abdin Henry Han bit.ly/3UxOEF3

🎙️ In this podcast episode, author David Kent, MD, MS, of Tufts Medicine and JAMA Associate Editor David Simel, MD, MHS, discuss how to evaluate the likelihood that a PFO was causal in a patient with a cryptogenic ischemic stroke. 🎧 Listen now: edhub.ama-assn.org/jn-learning/au…

📉 Who responds best to tirzepatide? Post hoc SURPASS-4 analysis ✅ Glycaemic control sustained in 75–84% 🔑 Predictors: higher dose, shorter T2DM duration, better β-cell function, metformin use, no albuminuria ✅ ≥10% weight loss sustained in 80% diabetesjournals.org/diabetes/artic…

Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial Dapagliflozin/spironolactone combination reduced NT-proBNP more than dapagliflozin. A greater eGFR decline and potassium

HFrEF ARNI+BB+MRA+SGLT2i Extend median survival by 7-11 YEARS Self-pay cash price for all 4 💊 $121 per month Available today

Wow, the game has changed! #SURPASSCVOT meets its primary & secondary endpoints in first *head-to-head* CV outcomes trial! Tirzepatide (dual GLP1/GIP agonist) vs Dulaglutide (GLP-1RA) including 16% lower risk of all cause mortality! investor.lilly.com/news-releases/…

New Algorithm for Estimating Left Ventricular Filling Pressure by Echocardiography The new algorithm increases the feasibility of estimating LVFP and has good accuracy with incremental value when natriuretic peptides are considered ahajournals.org/doi/abs/10.116…

In 1997, China didn’t even make the list. Today? It produces more cars than the U.S., Japan, India, and South Korea combined.

📌#HFrEF + secondary MR = a complex interplay. Optimal care demands: • Guideline-directed medical therapy💊 • Imaging-based timing • Heart team intervention (TEER, surgery) A holistic approach transforms outcomes. #HeartFailure #ValvularHeartDisease #StateOfTheArt #Review

Robots that can adapt, learn, and act are stepping out of the lab and into real roles. Embodied AI is making it possible, and the pace is picking up. How prepared is your business for what’s next? mck.co/4l56fyU

#ArtificialIntelligence applications in hypertrophic cardiomyopathy: turns and loopholes ow.ly/kXMF50Wwvoa #EHJDigital #DigitalTwin Nico Bruining EiC EHJ Digital Health rafavidalperez Folkert Asselbergs Ruben Casado Arroyo

This new GLP-1 could make Ozempic look outdated. Trial results show over 24% body weight loss in under a year. It works completely differently than anything on the market. 7 things you need to know about retatrutide:

In this pooled analysis of FINEARTS-HF, FIDELIO-DKD, and FIGARO-DKD, finerenone improved CV outcomes in >7,000 individuals with #HFmrEF/#HFpEF, supporting its use in HFmrEF/HFpEF across a broad range of #CKM risk jacc.org/doi/10.1016/j.… Gerasimos Filippatos Muthu Vaduganathan #GDMT #JACCHF

Acute coronary syndromes: mechanisms, challenges, and new opportunities: European Society of Cardiology Journals 🥸Very nice review - 😱Many research questions 👇👇👇

🥸2️⃣ Most ACS events are caused by coronary plaque rupture or plaque erosion, but other mechanisms include calcific nodules, embolism, spontaneous coronary artery dissection (SCAD), coronary spasm, and microvascular dysfunction.

🧵 Ferritin vs CRP – When High Iron Means High Fire CRP goes up in inflammation. Ferritin does too—but sometimes, it explodes. Let’s break down how ferritin behaves differently, and when to worry. 👇 Dr Ihab Suliman Dr. Akhil 🇮🇳 the EMCrit Crew Janet Pope Laurent ARNAUD #MedTwitter

Our immune system as we age: the path to immunosenesence and inflammaging science.org/doi/10.1126/sc…

A CT-based assessment of mitral annular calcification (MAC) revealed that leaflet involvement and calcium thickness >5 mm are independent predictors of mortality and heart failure hospitalization following TEER. ow.ly/SYo550WBWKC #TEER #StructuralHeart #Cardiology

📊 DAPA-MI Trial Randomised to dapagliflozin or placebo 📉 Key Results 🔻 New-onset T2DM risk ↓ Greatest benefit in BMI ≥30 + in those with prediabetes ✅Dapagliflozin may prevent T2DM & lower heart failure symptom burden post-MI Now off patent😜 ahajournals.org/doi/10.1161/JA…

New brain-targeting anti-obesity peptides (GLP-1, GIP, and dual agonists) access brain sites, such as the area postrema and arcuate nucleus, where they engage neurons controlling appetite, energy use, and reward response. By tapping into these circuits, they help suppress hunger